Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children
- 1 May 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (3) , 293-296
- https://doi.org/10.1111/j.1365-2230.2004.01501.x
Abstract
There are at least 13 scoring systems for the assessment of disease severity in atopic dermatitis (AD). Each system has its problems with interobserver and intraobserver variability. Cutaneous T-cell attracting chemokine (CTACK) is a skin-specific chemoattractant which may correlate with AD severity and obviate the issue of observer reliability. We evaluated whether serum CTACK concentrations were associated with the severity of AD in children according to the SCORing Atopic Dermatitis (SCORAD) index. Thirty-seven Chinese children with AD (23 boys, 14 girls; aged 1-11 years) and 13 controls were recruited. The median (interquartile range) overall SCORAD for AD patients was 29.7 (20.3-49.7). Serum concentrations of CTACK and two other atopy-related chemokines, macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC), were measured by sandwich enzyme immunoassay. There were significant correlations between SCORAD (r = 0.394, P = 0.016), its area (r = 0.528, P = 0.001) and intensity components (r = 0.429, P = 0.008) with serum levels of CTACK. The serum concentrations of inflammatory markers MDC and TARC also correlated with the CTACK concentrations (r = 0.618, P < 0.001, and r = 0.587, P = 0.001, respectively). Serum CTACK concentration appears to be a skin-specific objective marker that correlates with various clinical and laboratory parameters of AD.Keywords
This publication has 14 references indexed in Scilit:
- Serum concentration of macrophage‐derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young childrenPediatric Allergy and Immunology, 2003
- Plasma TARC concentration may be a useful marker for asthmatic exacerbation in childrenEuropean Respiratory Journal, 2003
- Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgarisJournal of Allergy and Clinical Immunology, 2003
- Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthmaJournal of Allergy and Clinical Immunology, 2002
- Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2002
- TARC in allergic diseaseAllergy, 2002
- Chemokines and the Tissue-Specific Migration of LymphocytesImmunity, 2002
- CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed SkinThe Journal of Experimental Medicine, 2001
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993